Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis

Respiratory Medicine

Volumn 104, Issue 4, 2010, Pages 534-541

  Monz, Brigitta U ^a   Sachs, Paul ^b,c   McDonald, Jeffrey ^d   Crawford, Bruce ^d   Nivens, Michael C ^e   Tetzlaff, Kay ^e,f  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b STAMFORD HOSPITAL   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d MAPI VALUES   (United States)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Chronic bronchitis; COPD; Cough and sputum assessment questionnaire; Exacerbations; Responsiveness

Indexed keywords

ADULT; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; QUESTIONNAIRE; SPUTUM ANALYSIS; SYMPTOM; BRONCHITIS, CHRONIC; COMPLICATION; COUGH; DISEASE COURSE; EVALUATION STUDY; HEALTH STATUS INDICATOR; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SECRETION (PROCESS); SEVERITY OF ILLNESS INDEX; SPUTUM; TREATMENT OUTCOME;

BRONCHITIS, CHRONIC; COUGH; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPUTUM; TREATMENT OUTCOME;

EID: 77349108110     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.10.026     Document Type: Article

References (20)

1. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
2. Crawford B., Monz B., Hohlfeld J., et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med 102 (2008) 1545-1555
3. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422
4. Miravitlles M., Murio C., Guerrero T., and Gisbert R. DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121 (2002) 1449-1455
5. Burge S., and Wedzicha J.A. COPD exacerbations: definitions and classifications. Eur Respir J 41 (2003) 46s-53s
6. Calverley P., Pauwels R., Lofdahl C.G., et al. Relationship between respiratory symptoms and medical treatment in exacerbation of COPD. Eur Respir J 26 (2005) 406-413
7. Leidy N.K., Rennard S.I., Schmier J., Jones M.K., and Goldman M. The breathlessness, cough, and sputum scale. The development of empirically based guidelines for interpretation. Chest 124 (2003) 2182-2191
8. Leidy N.K., Schmier J.K., Jones M.K., Lloyd J., and Rocchiccioli K. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the breathlessness, cough and sputum scale. Respir Med 97 Suppl. A (2003) S59-S70
9. Doll H., and Miravittles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Pharmacoeconomics 23 (2005) 345-363
10. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
11. Cohen J. Statistical power analysis for the behavioral sciences (1977), Academic Press
12. Seemungal T.A., Donaldson G.C., Bhowmik A., Jeffries D.J., and Wedzicha J.A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1608-1613
13. Vijayasaratha K., and Stockley R.A. Reported and unreported exacerbations of COPD. Chest 133 (2008) 34-41
14. Spencer S., Jones P.W., and GLOBE study group. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 58 (2003) 589-593
15. Revicki D., Hays R.D., Cella D., and Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61 2 (2008) 102-109
16. Scanlon P.D., Connett J.E., Waller L.A., Altose M.D., Bailey W.C., and Buist A.S. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The lung health study. Am J Respir Crit Care Med 161 (2000) 381-390
17. Lapperre T.S., Sont J.K., van Schadewijk A., et al. Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir Res 8 (2007) 85
18. Moore P.L. Practice management and chronic obstructive pulmonary disease in primary care. Am J Med 120 (2007) S23-S27
19. Tálamo C., de Oca M.M., Halbert R., et al. Diagnostic labeling of COPD in five Latin American cities. Chest 131 (2007) 60-67
20. Han M.K., Kim M.G., Mardon R., et al. Spirometry untilization for COPD. How do we measure up?. Chest 132 (2007) 403-409